Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid19 Prevention & Care; a Cancer Specific Guideline Publisher Pubmed



Motlagh A1, 2 ; Yamrali M3 ; Azghandi S4 ; Azadeh P2 ; Vaezi M4 ; Ashrafi F5 ; Zendehdel K6 ; Mirzaei H2 ; Basi A7 ; Rakhsha A2 ; Seifi S8 ; Tabatabaeefar M2 ; Elahi A9 ; Pirjani P10 Show All Authors
Authors
  1. Motlagh A1, 2
  2. Yamrali M3
  3. Azghandi S4
  4. Azadeh P2
  5. Vaezi M4
  6. Ashrafi F5
  7. Zendehdel K6
  8. Mirzaei H2
  9. Basi A7
  10. Rakhsha A2
  11. Seifi S8
  12. Tabatabaeefar M2
  13. Elahi A9
  14. Pirjani P10
  15. Moadab Shoar L3
  16. Nadarkhani F11
  17. Khoshabi M12
  18. Bahar M13
  19. Esfahani F8, 14
  20. Fudazi H15
  21. Samiei F16, 17
  22. Farazmand B18
  23. Ahmari A19
  24. Rajabpour MV6
  25. Janbabaei G4, 20
  26. Raisi A21, 22
  27. Ostovar A1, 23
  28. Malekzadeh R1, 24, 25
Show Affiliations
Authors Affiliations
  1. 1. National Cancer Control Secretariat, Ministry of Health and Medical Education, Tehran, Iran
  2. 2. Department of Radiation Oncology, Shaheed Beheshti Medical University, Tehran, Iran
  3. 3. Department of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Hematology Oncology, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Hematology Oncology, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Hematology Oncology, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Hematology Oncology, Shaheed Beheshti Medical University, Tehran, Iran
  9. 9. Department of Surgery, Alborz University of Medical Sciences, Karaj, Iran
  10. 10. Ala Cancer Prevention and Control Center (MACSA), Tehran, Iran
  11. 11. Standard and Clinical Guidelines Department, Ministry of Health and Medical Education, Tehran, Iran
  12. 12. Department of Geospatial Information System (GIS), Center of Excellence in GIS, K.N. Toosi Uni. of Technology, Tehran, Iran
  13. 13. Behnam Daheshpour Charity Organization, Tehran, Iran
  14. 14. Iranian Society of Medical Oncology and Hematology, Tehran, Iran
  15. 15. Iranian Society of Radiation Oncology, Tehran, Iran
  16. 16. Iranian Cancer Association, Tehran, Iran
  17. 17. Department of Radiation Oncology, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Department of Radiation Oncology, Mashhad University of Medical Sciences, Ghouchan, Iran
  19. 19. Department of Radiation Oncology, Arak University of Medical Sciences, Arak, Iran
  20. 20. Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran
  21. 21. Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  22. 22. Deputy of Public Health, Ministry of Health and Medical Education, Tehran, Iran
  23. 23. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  24. 24. Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  25. 25. Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran

Source: Archives of Iranian Medicine Published:2020


Abstract

On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: First, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses. © 2020 Academy of Medical Sciences of I.R. Iran. All rights reserved.
Other Related Docs
18. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
19. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
28. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
32. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
34. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
35. Important Guidelines for Surgery in Covid-19 Pandemic; a Review Study, Journal of Isfahan Medical School (2021)
45. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)